Bioquell Z-2 HPV bio-decontamination system
Targeted at the pharmaceutical, biotech and healthcare industries, the Bioquell Z-2 hydrogen peroxide vapour (HPV) generator is a complete solution for room/zone bio-decontamination offering user-friendly operation with parametric cycle control, eliminating the necessity for gas cycle development studies (non-GMP facilities).
With Australian C-Tick approval, the product incorporates a HPV generator, gas distribution and catalytic aeration in a single mobile system. The system is operated with user-friendly touch-screen controls and can bio-decontaminate areas up to 250 m3 using parametric control. Larger volumes can be validated using timed cycles.
A menu-driven interface makes it easy to set cycle parameters. A graphical display shows the bio-decontamination cycle progress in real time and a communication port allows remote control via a building management system (BMS). Dual-circuit technology enables fast, efficient bio-decontamination cycles without the need for room preconditioning or dehumidification. The system also includes a room-measuring device and handheld hydrogen peroxide vapour monitor.
HPV biological decontamination is replacing traditional formaldehyde techniques which are known to be hazardous to health, difficult to control and validate. The product uses 30-35% w/w hydrogen peroxide which has been approved by the regulatory bodies Biocidal Products Directive (BPD) and the US EPA.
Bio-decontamination cycles with the product have been verified by inactivation of 6-log Geobacillus stearothermophilus, the industry-standard biological indicator (BI) used to validate steam sterilisers/autoclaves.
Phone: 02 9575 7512
Lumiprobe DusQ fluorescence quenchers
Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...
Enzo Life Sciences SCREEN-WELL Epigenetics library
Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...
LSBio PathPlus Cancer Antibodies
The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer...